Crossject Stock
Stocks
ALCJ
FR0011716265
Medical Equipment, Supplies & Distribution
OTC Markets Traded|
Market Closed -
Euronext Paris
11:55:00 2026-10-06 am EDT
|
After hours 02:34:44 pm | |||
| 1.346 EUR | +2.75% |
|
1.341 | -0.37% |
| Sep. 25 | Crossject: H126. Quid novi sub sole? Not much. | AL |
| Sep. 25 | Crossject Société Anonyme Reports Earnings Results for the Half Year Ended June 30, 2026 | CI |
| Market Cap | 71.32M 80.34M 66.74M 60.5M 114M 7.75B 115M 802M 312M 3.95B 302M 295M 12.7B | P/E 2026 * |
3.2x | P/E 2027 * | 2.52x |
|---|---|---|---|---|---|
| Enterprise Value | 53.42M 60.18M 49.99M 45.31M 85.58M 5.8B 86.2M 600M 234M 2.96B 226M 221M 9.51B | EV / Sales 2026 * |
0.88x | EV / Sales 2027 * | 0.37x |
| Free-Float |
92.46% | Yield 2026 * |
-
| Yield 2027 * | - |
| Markets | Quality | ||
|---|---|---|---|
Euronext Paris
| ALCJ | Real-time | |
CBOE
| Real-time | ||
Tradegate
| 74C | Real-time | |
Deutsche Boerse AG
| 74C | Delayed | |
Börse Stuttgart
| 74C | Delayed | |
Boerse Muenchen
| 74C | Real-time | |
CBOE
| Real-time |
| Sep. 25 | Crossject: H126. Quid novi sub sole? Not much. | AL |
| May. 26 | Crossject: The last round of financing? | AL |
| Mar. 30 | Crossject: Integrating the FY25 numbers | AL |
| Mar. 25 | Crossject: FY25 results: no big change. | AL |
| Nov. 17 | Crossject: Yet another round of financing | AL |
| 1 day | +2.75% | ||
| 1 week | -0.30% | ||
| Current month | -2.46% | ||
| 1 month | -3.86% | ||
| 3 months | -22.64% | ||
| 6 months | -32.87% | ||
| Current year | -38.54% |
| 1 week | 1.29 | 1.41 | |
| 1 month | 1.19 | 1.44 | |
| Current year | 1.19 | 2.58 | |
| 1 year | 1.19 | 2.7 | |
| 3 years | 0.72 | 5.96 | |
| 5 years | 0.72 | 5.96 | |
| 10 years | 0.72 | 7.25 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 63 | 2001-08-07 | |
Lionel Seltz
DFI | Director of Finance/CFO | - | 2026-03-24 |
Tony C. Tipton
PRN | Corporate Officer/Principal | - | 2024-08-19 |
| Director | Title | Age | Since |
|---|---|---|---|
Philippe Monnot
CHM | Chairman | 67 | 2009-06-25 |
Eric Nemeth
BRD | Director/Board Member | 67 | - |
| Director/Board Member | - | - |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 7/4/25 | Buy | Director | 13,386 | 0.0266% | ||
| 7/1/25 | Buy | Director | 50 | 0.0001% | ||
| 7/1/25 | Buy | Director | 337 | 0.0007% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +2.75% | -0.30% | -37.10% | -64.06% | 79.95M | ||
| -1.89% | -2.51% | -26.41% | +1.58% | 173B | ||
| -1.71% | -0.29% | -11.78% | +14.08% | 113B | ||
| -2.30% | +0.05% | -23.85% | +4.91% | 109B | ||
| +1.52% | +1.45% | -46.87% | -10.58% | 74.44B | ||
| -0.46% | +2.45% | +3.22% | +71.41% | 60.1B | ||
| +3.27% | +7.25% | +18.14% | +67.16% | 51.87B | ||
| -0.05% | -0.48% | -5.67% | -30.99% | 49.21B | ||
| -2.66% | -3.73% | -18.20% | +15.14% | 41.52B | ||
| -4.18% | -3.66% | +25.78% | +0.30% | 32.79B | ||
| Average | -0.53% | +0.86% | -12.27% | +6.90% | 70.52B | |
| Weighted average by Cap. | -1.05% | +0.42% | -15.68% | +12.04% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 60.8M 68.49M 56.9M 51.57M 97.4M 6.6B 98.1M 683M 266M 3.37B 257M 252M 10.83B | 65.2M 73.45M 61.01M 55.3M 104M 7.08B 105M 733M 285M 3.61B 276M 270M 11.61B |
| Net income | 28.3M 31.88M 26.48M 24M 45.33M 3.07B 45.66M 318M 124M 1.57B 120M 117M 5.04B | 35.6M 40.1M 33.31M 30.2M 57.03M 3.87B 57.44M 400M 156M 1.97B 151M 147M 6.34B |
| Net Debt | -17.9M -20.16M -16.75M -15.18M -28.67M -1.94B -28.88M -201M -78.25M -992M -75.69M -74.07M -3.19B | -47M -52.95M -43.98M -39.87M -75.29M -5.1B -75.83M -528M -205M -2.6B -199M -194M -8.37B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-10-06 | €1.346 | +2.75% | 204,373 |
| 26-10-05 | €1.310 | 0.00% | 62,564 |
| 26-10-02 | €1.310 | -2.96% | 119,215 |
| 26-10-01 | €1.350 | -2.17% | 88,486 |
| 26-09-30 | €1.380 | +2.22% | 85,077 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.

Annual profits - Rate of surprise
- Stock Market
- Stocks
- ALCJ Stock
Select your edition
All financial news and data tailored to specific country editions

















